Potential lawsuits are currently being considered regarding individuals who have experienced kidney or renal failure as the result of taking Invokana*, a new generation diabetes drug that has been linked to renal damage and other kidney problems. What is Invokana? Invokana is part of a…
A recent study published in the Journal of the American Medical Association (JAMA) suggests that although more than two dozen dietary supplements were recalled by the Food and Drug Administration (FDA), approximately two-thirds were back on the market a year later, with the same banned…
Transvaginal mesh devices are surgically implanted in women to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI). The devices are designed to prevent internal organs from coming into contact with each other, but have resulted in numerous complications for patients, including: M
A new study released for the 2015 annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) links Mirena exposure to the development of IIH (idiopathic intracranial hypertension) also known as pseudotumor celebri (PTC). Mirena is a type of long-acting, reversible hormonal in
According to a study conducted by researchers for Johns Hopkins Bloomberg School of Public Health and George Washington University that was published on April 24, 2015 in the British Medical Journal, Xarelto may present double warfarin’s risk of serious gastrointestinal bleeds, and Pradaxa may incre
The Food & Drug Administration on March 12, 2015 announced a Class 2 Recall of about 11,658 Zimmer Persona knee implant Tibial components parts because of radiolucent lines and premature loosening. Distributed from 2012 through January 2015 due to the recall, the Persona knee was…
Prescription medications for low testosterone levels, also known as “Low T” have been heavily advertised to U.S. men in recent years, and as a result, the sale of testosterone replacement treatments have risen substantially during the last 10 years. What is Testosterone? Testosterone is a…
The U.S. Food and Drug Administration (FDA) has rejected three attempts by Johnson & Johnson to expand the approval of its anti-blood clotting drug, Xarelto, according to a report in the Wall Street Journal. Xarelto is approved as a preventative medicine for patients with pulmonary…
On Friday, February 20, 2015, DePuy/ Johnson & Johnson agreed to pay approximately $420 million more to resolve approximately 1400 additional DePuy ASR lawsuits. The order came from the Court extending the settlement offer to Plaintiffs who had revision surgery after August 31, 2013 up…
On December 22, 2014, China officially approved imports of a type of genetically modified corn – Syngenta’s Agrisure Viptera® MR162, ending China’s yearlong ban of imports of all corn containing any trace of the Viptera MR162 trait. The ban had essentially shut U.S. corn out…
Our firm is proud to be a part of the Boys and Girls Club’s 2014 holiday gift program. We are helping to ensure that 50 children in need receive gifts this Holiday Season. We are also sponsoring two deserving families in need of help. We…
Purdue, maker of the painkiller OxyContin, has won dismissals in over 400 personal injury lawsuits related to the medication, has settled product liability cases involving the drug without disclosing the terms, and has defeated more than ten class actions suits brought against it over the…
